Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of Preemptive Multimodal Analgesic on Endodontic Pain
NCT07400471Phase 1Recruiting
- Sponsor
- Chattogram International Dental College
- Start
- Feb 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of pregabalin and duloxetine (3 arms), sponsored by Chattogram International Dental College. Primary endpoint: Effects of Preemptive multimodal analgesia on post endodontic pain at 72 hours. Started Feb 2026; status: recruiting.
02
Drugs
pregabalinduloxetine
Beyond the preview
Go deeper on NCT07400471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400471.